Newsletter Signup | Join Community | Cancer Types
Management of bile duct cancers - treatment may consist of surgery, liver transplant and precision cancer medicines
Selective internal radiotherapy may be effective for the down staging of patients with unresectable Cholangiocarcinoma
REFLECT clinical trial leads to approval of Lenvima for treatment of liver cancer - Keytruda combination more promising.
Cyramza Improves Survival in Poor-Prognosis Liver Cancer
Stay Current With Liver Cancer Treatment Advances & Connect with Others
Radiotherapy Offers New Treatment Option for Liver Cancer
Live Web Chat with the Expert: Treatment Options for Patients with Liver Cancer
Oncology Experts Talk About Surgery, Radiation Therapy, Chemotherapy, for Primary Hepatocellular Carcinoma.
Antiviral Therapy May Reduce the Risk of Tumor Recurrence in HBV-Related Liver Cancer
Sutent® Not Effective for Advanced Liver Cancer
Antiviral Therapy for Hepatitis C May Prevent Liver Cancer
Statins Linked to Lower Risk of Liver Cancer in Hepatitis C
Differences in IMRT Radiation Doses May Complicate Study Results in Liver Cancer
Nexavar® Effective for Hepatocellular Carcinoma in Asians
Increased Risk of Liver Cancer for Patients with Cirrhosis Who Overexpress EGF
Interferon Therapy Prevents Recurrences Following Surgery for Liver Cancer
Study Identifies Risk Factors Including Hepatitis C and Alcohol for Developing Hepatocellular Carcinoma (Liver Cancer)
Risk of Hepatocellular Carcinoma Linked with Serum Levels of Hepatitis B Virus DNA
Lamivudine Decreases Risk of Liver Cancer in Patients with Hepatitis B.
Colchicine May Reduce Risk of Liver Cancer in Patients with Hepatitis-related Cirrhosis
FDA Grants Orphan Drug Status to Investigational Liver Cancer Drug
Nexavar® Improves Survival in Advanced Liver Cancer
Women with Hypothyroidism at Increased Risk of Liver Cancer
Nexavar® Provides Activity in Some Patients with Liver Cancer
Genes Outside of Cancer Help Predict Outcomes of Liver Cancer Patients
Liver Cancer Incidence is on the Rise in the United States
Avastin® plus Tarceva® Shows Promise in Advanced Hepatocellular Carcinoma
Nexavar® Improves Survival in Advanced Hepatocellular Carcinoma
Nexavar Superior to Sutent in Liver Cancer
Patients with Hepatitis C with Long-Term Responses to Interferon Have Low Rate of Liver Cancer.
Addition of Nexavar® to Adriamycin® Improves Survival in Hepatocellular Carcinoma
Interferon Following Surgery May Improve Survival in Advanced Liver Cancer
It is estimated that 100,000 to 150,000 people acquire the hepatitis B virus every year in the United States.
Occult Hepatitis B Infection Linked with Liver Cancer
New Treatment Combination for Bile Duct Cancer May Improve Surviva
Risk Factors Predict for the Development of Liver Cancer in Patients with Liver Cirrhosis
Photodynamic Therapy Improves Survival with Bile Duct Cancer
Liver Cancer Screening in Patients with Chronic Hepatitis B and C Improves Survival
Liver Cancer Often Linked to Diabetes
Nexavar® Added to Treatment Guidelines for Liver Cancer.
Anti-Viral Epivir® Prevents Inflammation of the Liver Due to Reactivation of Hepatitis B in Liver Cancer Patients
I-131-Lipidiol Reduce Recurrences in Persons Who Have Surgery for Liver Cancer
Good Results After Liver Transplantation for Childhood Liver Cancer
Early Recurrence Associated with Poorer Prognosis in Patients with Liver Cancer Who Undergo Surgery